© Copyright 2026, All Rights Reserved
Monitor minimal residual disease in cancer patients; Detect relevant mutations early in treatment; Analyze genetic alterations for personalized therapy; Profile tumors for targeted treatment strategies; Quantify circulating tumor DNA in blood samples.
Notable partnerships with universities and biotech firms; Engaged in multiple government-funded research projects; Focused on improving early cancer diagnosis through advanced technologies.
Main Information
Contact & Links
Key Information
Company Context